Orient Pharma Co., Ltd. (TPEX: 4166)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
37.10
-0.95 (-2.50%)
Dec 19, 2024, 2:59 PM CST
82.31%
Market Cap 8.25B
Revenue (ttm) 1.07B
Net Income (ttm) 119.10M
Shares Out 223.04M
EPS (ttm) 0.53
PE Ratio 69.29
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 329,469
Open 38.00
Previous Close 38.05
Day's Range 34.50 - 38.10
52-Week Range 19.45 - 50.70
Beta 0.15
Analysts n/a
Price Target n/a
Earnings Date Nov 28, 2024

About Orient Pharma

Orient Pharma Co., Ltd. engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally. The company develops anti-psychotics and psychostimulants, as well as drugs for treating Parkinson’s and Alzheimer’s diseases; and products for the treatment of sialorrhea, tuberculosis, and attention deficit hyperactivity disorder. It is also developing drug delivery technologies, such as multi-stages-controlled release technology, trans-dermal patches, oral disintegrating tablets, sustained release technology, and ... [Read more]

Sector Healthcare
Founded 2008
Employees 173
Stock Exchange Taipei Exchange
Ticker Symbol 4166
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.